Androgen regulation of β-amyloid protein and the risk of Alzheimer's disease

Brain Research Reviews

Volumn 57, Issue 2, 2008, Pages 444-453

  Rosario, Emily R ^a   Pike, Christian J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Amyloid; Alzheimer's disease; Androgen; Dihydrotestosterone; Estrogen; Testosterone

Indexed keywords

AMYLOID BETA PROTEIN; ANDROGEN; ANDROSTANOLONE; ESTROGEN; FLUTAMIDE; GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; MEMBRANE METALLOENDOPEPTIDASE; MITOGEN ACTIVATED PROTEIN KINASE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGING; ALZHEIMER DISEASE; CELL CULTURE; COGNITION; FEEDBACK SYSTEM; GONADECTOMY; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANDROGENS; ANIMALS; BRAIN; HUMANS; MALE; RISK FACTORS; TESTOSTERONE;

EID: 40749099059     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2007.04.012     Document Type: Review

References (111)

1. Ahlbom E., Prins G.S., and Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 892 (2001) 255-262
2. Alexander G.M., Swerdloff R.S., Wang C., Davidson T., McDonald V., Steiner B., and Hines M. Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities. Horm. Behav. 33 (1998) 85-94
3. Almeida T.A., and Papadopoulos N. Progression model of prostate cancer. Methods Mol. Biol. 222 (2003) 211-222
4. Azcoitia I., Sierra A., Veiga S., Honda S., Harada N., and Garcia-Segura L.M. Brain aromatase is neuroprotective. J. Neurobiol. 47 (2001) 318-329
5. Barrett-Connor E., Goodman-Gruen D., and Patay B. Endogenous sex hormones and cognitive function in older men. J. Clin. Endocrinol Metab. 84 (1999) 3681-3685
6. Barron A.M., Verdile G., and Martins R.N. The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms. Endocrine 29 (2006) 257-269
7. Baumgartner R.N., Waters D.L., Gallagher D., Morley J.E., and Garry P.J. Predictors of skeletal muscle mass in elderly men and women. Mech. Ageing Dev. 107 (1999) 123-136
8. Beyer C., and Hutchison J.B. Androgens stimulate the morphological maturation of embryonic hypothalamic aromatase-immunoreactive neurons in the mouse. Dev. Brain Res. 98 (1997) 74-81
9. Bowen R.L., Isley J.P., and Atkinson R.L. An association of elevated serum gonadotropin concentrations and Alzheimer disease?. J. Neuroendocrinol. 12 (2000) 351-354
10. Bowen R.L., Verdile G., Liu T., Parlow A.F., Perry G., Smith M.A., Martins R.N., and Atwood C.S. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J. Biol. Chem. 279 (2004) 20539-20545
11. Brookmeyer R., Gray S., and Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 88 (1998) 1337-1342
12. Brooks B.P., Merry D.E., Paulson H.L., Lieberman A.P., Kolson D.L., and Fischbeck K.H. A cell culture model for androgen effects in motor neurons. J. Neurochem. 70 (1998) 1054-1060
13. Burkhardt M.S., Foster J.K., Clarnette R.M., Chubb S.A., Bruce D.G., Drummond P.D., Martins R.N., and Yeap B.B. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men. J. Clin. Endocrinol. Metab. 91 (2006) 1168-1172
14. Burger H., de Laet C.E., van Daele P.L., Weel A.E., Witteman J.C., Hofman A., and Pols H.A. Risk factors for increased bone loss in an elderly population: the Rotterdam Study. Am. J. Epidemiol. 147 (1998) 871-879
15. Casadesus G., Zhu X., Atwood C.S., Webber K.N., Perry G., Bowen R.L., and Smith M.A. Curr. Drug Targets CNS Neurol. Dis. 3 (2004) 28-285
16. Casadesus G., Webber K.M., Atwood C.S., Pappolla M.A., Perry G., Bowen R.L., and Smith M.A. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim. Biophys. Acta 1762 (2006) 447-452
17. Chang D., Kwan J., and Timiras P.S. Estrogens influence growth, maturation, and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line. Adv. Exp. Med. Biol. 429 (1997) 261-271
18. Cherrier M.M., Rose A.L., and Higano C. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J. Urol. 170 (2003) 1808-1811
19. Cherrier M.M., Matsumoto A.M., Amory J.K., Asthana S., Bremner W., Peskind E.R., Raskind M.A., and Craft S. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 64 (2005) 2063-2068
20. Davidson J.M., Chen J.J., Crapo L., Gray G.D., Greenleaf W.J., and Catania J.A. Hormonal changes and sexual function in aging men. J. Clin. Endocrinol. Metab. 57 (1983) 71-77
21. Day J.R., Frank A.T., O'Callaghan J.P., Jones B.C., and Anderson J.E. The effect of age and testosterone on the expression of glial fibrillary acidic protein in the rat cerebellum. Exp. Neurol. 151 (1998) 343-346
22. Evans D.A., Funkenstein H.H., Albert M.S., Scherr P.A., Cook N.R., Chown M.J., Hebert L.E., Hennekens C.H., and Taylor J.O. Prevalence of Alzheimer's disease in a community population of older persons Higher than previously reported. JAMA 262 (1989) 2551-2556
23. Feldman H.A., Longcope C., Derby C.A., Johannes C.B., Araujo A.B., Coviello A.D., Bremner W.J., and McKinlay J.B. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J. Clin. Endocrinol Metab. 87 (2002) 589-598
24. Ferrando A.A., Sheffield-Moore M., Yeckel C.W., Gilkison C., Jiang J., Achacosa A., Lieberman S.A., Tipton K., Wolfe R.R., and Urban R.J. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am. J. Physiol: Endocrinol. Metab. 282 (2002) E601-E607
25. Frye C.A., and Reed T.A. Androgenic neurosteroids: antiseizure effects in an animal model of epilepsy. Psychoneuroendocrinology 23 (1998) 385-399
26. Gandy S., Almeida O.P., Fonte J., Lim D., Waterrus A., Spry N., Flicker L., and Martins R.N. Chemical andropause and amyloid-beta peptide. JAMA 285 (2001) 2195-2196
27. Gillett M.J., Martins R.N., Clarnette R.M., Chubb S.A., Bruce D.G., and Yeap B.B. Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia. J. Alzheimer's Dis. 5 (2003) 267-269
28. Goldenberg S.L., Bruchovsky N., Gleave M.E., Sullivan L.D., and Akakura K. Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report. Urology 45 (1995) 839-844
29. Goodenough S., Engert S., and Behl C. Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neurosci. Lett. 296 (2000) 49-52
30. Gooren L. Androgen deficiency in the aging male: benefits and risks of androgen supplementation. J. Steroid Biochem. Mol. Biol. 85 (2003) 349-355
31. Gouchie C., and Kimura D. The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology 16 (1991) 323-334
32. Gouras G.K., Xu H., Gross R.S., Greenfield J.P., Hai B., Wang R., and Greengard P. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1202-1205
33. Gray A., Feldman H.A., McKinlay J.B., and Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 73 (1991) 1016-1025
34. Green H.J. Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing analogues and cyproterone acetate: a randomized controlled trial. BJU Int. 90 (2002) 427-432
35. Green P.S., Bales K., Paul S., and Bu G. Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease. Endocrinology 146 (2005) 2774-2781
36. Greenfield J.P., Leung L.W., Cai D., Kaasik K., Gross R.S., Rodriguez_Boulan E., Greengard P., and Xu H. Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J. Biol. Chem. 277 (2002) 12128-12136
37. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M., and LeBlanc A. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 77 (2001) 1319-1326
38. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
39. Haren M.T., Wittert G.A., Chapman I.M., Coates P., and Morley J.E. Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas 50 (2005) 124-133
40. Harman S.M., Metter E.J., Tobin J.D., Pearson J., and Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 86 (2001) 724-731
41. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., and Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60 (2003) 1119-1122
42. Heikkinen T., Kalesnykas G., Rissanen A., Tapiola T., Iivonen S., Wang J., Chaudhuri J., Tanila H., Miettinen R., and Puolivali J. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation. Exp. Neurol. 187 (2004) 105-117
43. Hogervorst E., Williams J., Budge M., Barnetson L., Combrinck M., and Smith A.D. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol. Lett. 22 (2001) 163-168
44. Hogervorst E., Lehmann D.J., Warden D.R., McBroom J., and Smith A.D. Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men. Int. J. Geriatr. Psychiatry 17 (2002) 938-940
45. Hogervorst E., Combrinck M., and Smith A.D. Testosterone and gonadotropin levels in men with dementia. Neuroendocrinol. Lett. 24 (2003) 203-208
46. Huang J., Guan H., Booze R.M., Eckman C.B., and Hersh L.B. Estrogen regulates neprilysin activity in rat brain. Neurosci. Lett. 367 (2004) 85-87
47. Jaffe A.B., Toran_Allerand C.D., Greengard P., and Gandy S.E. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 269 (1994) 13065-13068
48. Janowsky J.S., Oviatt S.K., and Orwoll E.S. Testosterone influences spatial cognition in older men. Behav. Neurosci. 108 (1994) 325-332
49. Jones R.D., Pugh P.J., Hall J., Channer K.S., and Jones T.H. Altered circulating hormone levels, endothelial function and vascular reactivity in the testicular feminised mouse. Eur. J. Endocrinol. 148 (2003) 111-120
50. Jorm A.F., Korten A.E., and Henderson A.S. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr. Scand. 76 (1987) 465-479
51. Kaufman J.M., and Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 26 (2005) 833-876
52. Kerr J.E., Allore R.J., Beck S.G., and Handa R.J. Distribution and hormonal regulation of androgen receptor (AR) and AR messenger ribonucleic acid in the rat hippocampus. Endocrinology 136 (1995) 3213-3221
53. Kovacs E.G., MacLusky N.J., and Leranth C. Effects of testosterone on hippocampal CA1 spine synaptic density in the male rat are inhibited by fimbria/fornix transection. Neuroscience 122 (2003) 807-810
54. Kujawa K.A., Kinderman N.B., and Jones K.J. Testosterone-induced acceleration of recovery from facial paralysis following crush axotomy of the facial nerve in male hamsters. Exp. Neurol. 105 (1989) 80-85
55. Kujawa K.A., Emeric E., and Jones K.J. Testosterone differentially regulates the regenerative properties of injured hamster facial motoneurons. J. Neurosci. 11 (1991) 3898-3906
56. Leranth C., Petnehazy O., and MacLusky N.J. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J. Neurosci. 23 (2003) 1588-1592
57. Leranth C., Prange-Kiel J., Frick K.M., and Horvath T.L. Low CA1 spine synapse density is further reduced by castration in male non-human primates. Cereb. Cortex 14 (2004) 503-510
58. Levin-Allerhand J.A., Lominska C.E., Wang J., and Smith J.D. alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice. J. Alzheimers Dis. 4 (2002) 449-457
59. Lu P.H., Masterman D.A., Mulnard R., Cotman C., Miller B., Yaffe K., Reback E., Porter V., Swerdloff R., and Cummings J.L. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch. Neurol. 63 (2006) 177-185
60. Lund T.D., Salyer D.L., Fleming D.E., and Lephart E.D. Pre- or postnatal testosterone and flutamide effects on sexually dimorphic nuclei of the rat hypothalamus. Dev. Brain Res. 120 (2000) 261-266
61. Lund T.D., Hinds L.R., and Handa R.J. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus. J. Neurosci. 26 (2006) 1448-1456
62. Manni A., Pardridge W.M., Cefalu W., Nisula B.C., Bardin C.W., Santner S.J., and Santen R.J. Bioavailability of albumin-bound testosterone. J. Clin. Endocrinol. Metab. 61 (1985) 705-710
63. Manthey D., Heck S., Engert S., and Behl C. Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur. J. Biochem. 268 (2001) 4285-4291
64. Marks L.S., Mazer N.A., Mostaghel E., Hess D.L., Dorey F.J., Epstein J.I., Veltri R.W., Makarov D.V., Partin A.W., Bostwick D.G., Macairan M.L., and Nelson P.S. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA 296 (2006) 2351-2361
65. Marron T.U., Guerini V., Rusmini P., Sau D., Brevini T.A., Martini L., and Poletti A. Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones. J. Neurochem. 92 (2005) 10-20
66. Matsumoto A. Hormonally induced neuronal plasticity in the adult motoneurons. Brain Res. Bull. 44 (1997) 539-547
67. Meier D.E., Orwoll E.S., Keenan E.J., and Fagerstrom R.M. Marked decline in trabecular bone mineral content in healthy men with age: lack of association with sex steroid levels. J. Am. Geriatr. Soc. 35 (1987) 189-197
68. Moffat S.D., Zonderman A.B., Metter E.J., Blackman M.R., Harman S.M., and Resnick S.M. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J. Clin. Endocrinol. Metab. 87 (2002) 5001-5007
69. Moffat S.D., Zonderman A.B., Metter E.J., Kawas C., Blackman M.R., Harman S.M., and Resnick S.M. Free testosterone and risk for Alzheimer disease in older men. Neurology 62 (2004) 188-193
70. Morley J.E. Androgens and aging. Maturitas 38 (2001) 61-71
71. Morley J.E., Kaiser F.E., Perry H.M., Patrick P., Morley P.M., Stauber P.M., Vellas B., Baumgartner R.N., and Garry P.J. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab. Clin. Exp. 46 (1997) 410-413
72. Muller M., den Tonkelaar I., Thijssen J.H., Grobbee D.E., and van der Schouw Y.T. Endogenous sex hormones in men aged 40-80 years. Eur. J. Endocrinol. 149 (2003) 583-589
73. Nguyen T.V., Yao M., and Pike C.J. Androgens activate mitogen activated protein kinase signaling: role in neuroprotection. J. Neurochem. 94 (2005) 1639-1651
74. Nordeen E.J., Nordeen K.W., Sengelaub D.R., and Arnold A.P. Androgens prevent normally occurring cell death in a sexually dimorphic spinal nucleus. Science 229 (1985) 671-673
75. Nuñez J.L., Jurgens H.A., and Juraska J.M. Androgens reduce cell death in the developing rat visual cortex. Dev. Brain Res. 125 (2000) 83-88
76. Paoletti A.M., Congia S., Lello S., Tedde D., Orru M., Pistis M., Pilloni M., Zedda P., Loddo A., and Melis G.B. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology 62 (2004) 301-303
77. Pardridge W.M. Transport of protein-bound hormones into tissues in vivo. Endocr. Rev. 2 (1985) 103-123
78. Pardridge W.M. Serum bioavailability of sex steroid hormones. Clin. Endocrinol. Metab. 15 (1986) 259-278
79. Pennanen C., Laakso M.P., Kivipelto M., Ramberg J., and Soininen H. Serum testosterone levels in males with Alzheimer's disease. J. Neuroendocrinol. 16 (2004) 95-98
80. Petanceska S.S., Nagy V., Frail D., and Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp. Gerontol. 35 (2000) 1317-1325
81. Pike C.J. Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res. 919 (2001) 160-165
82. Pike C.J., Rosario E.R., and Nguyen T.V. Androgens, aging, and Alzheimer's disease. Endocrine 29 (2006) 233-241
83. Purifoy F.E., Koopmans L.H., and Mayes D.M. Age differences in serum androgen levels in normal adult males. Hum. Biol. 53 (1981) 499-511
84. Raber J., Bongers G., LeFevour A., Buttini M., and Mucke L. Androgens protect against apolipoprotein E4-induced cognitive deficits. J. Neurosci. 22 (2002) 5204-5209
85. Ramsden M., Shin T.M., and Pike C.J. Androgens modulate neuronal vulnerability to kainate lesion. Neuroscience 122 (2003) 573-578
86. Ramsden M., Nyborg A.C., Murphy M.P., Chang L., Stanczyk F.Z., Golde T.E., and Pike C.J. Androgens modulate beta-amyloid levels in male rat brain. J. Neurochem. 87 (2003) 1052-1055
87. Rasmuson S., Nasman B., Carlstrom K., and Olsson T. Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease. Dement. Geriatr. Cognit. Disord. 13 (2002) 74-79
88. Raynaud J.P. Prostate cancer risk in testosterone-treated men. J. Steroid Biochem. Mol. Biol. 102 (2006) 261-266
89. Rocca W.A., Amaducci L.A., and Schoenberg B.S. Epidemiology of clinically diagnosed Alzheimer's disease. Ann. Neurol. 19 (1986) 415-424
90. Rosario E.R., Chang L., Stanczyk F.Z., and Pike C.J. Age-related testosterone depletion and the development of Alzheimer disease. JAMA 292 (2004) 1431-1432
91. Rosario E.R., Carroll J.C., Oddo S., LaFerla F.M., and Pike C.J. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J. Neurosci. 26 (2006) 13384-13389
92. Salminen E.K., Portin R.I., Koskinen A., Helenius H., and Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin. Cancer Res. 10 (2004) 7575-7582
93. Savage M.J., Trusko S.P., Howland D.S., Pinsker L.R., Mistretta S., Reaume A.G., Greenberg B.D., Siman R., and Scott R.W. Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18 (1998) 1743-1752
94. Sheffield-Moore M., and Urban R.J. An overview of the endocrinology of skeletal muscle. Trends Endocrinol. Metab. 15 (2004) 110-115
95. Short R.A., Bowen R.L., O'Brien P.C., and Graff-Radford N.R. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin. Proc. 76 (2001) 906-909
96. Simerly R.B., Chang C., Muramatsu M., and Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294 (1990) 76-95
97. Swerdloff R.S., and Wang C. Androgen deficiency and aging in men. West. J. Med. 159 (1993) 579-585
98. Swerdloff R.S., and Wang C. Androgens and aging in men. Exp. Gerontol. 28 (2002) 435-446
99. Tan R.S., and Pu S.J. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male 6 (2003) 13-17
100. Tohgi H., Utsugisawa K., Yamagata M., and Yoshimura M. Effects of age on messenger RNA expression of glucocorticoid, thyroid hormone, androgen, and estrogen receptors in postmortem human hippocampus. Brain Res. 700 (1995) 245-253
101. Twist S.J., Taylor G.A., Weddell A., Weightman D.R., Edwardson J.A., and Morris C.M. Brain oestradiol and testosterone levels in Alzheimer's disease. Neurosci. Lett. 286 (2000) 1-4
102. Vermeulen A., Kaufman J.M., and Giagulli V.A. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J. Clin. Endocrinol. Metab. 81 (1996) 1821-1826
103. Vincent B., and Smith J.D. Effect of estradiol on neuronal Swedish-mutated beta-amyloid precursor protein metabolism: reversal by astrocytic cells. Biochem. Biophys. Res. Commun. 271 (2000) 82-85
104. Watanabe T., Koba S., Kawamura M., Itokawa M., Idei T., Nakagawa Y., Iguchi T., and Katagiri T. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism 53 (2004) 476-482
105. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., Liao F., Checler F., Buxbaum J.D., Chait B.T., Thinakaran G., Sisodia S.S., Wang R., Greengard P., and Gandy S. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 4 (1998) 447-451
106. Yu W.H. Effect of testosterone on the regeneration of the hypoglossal nerve in rats. Exp. Neurol. 77 (1982) 129-141
107. Yu W.H. Administration of testosterone attenuates neuronal loss following axotomy in the brain-stem motor nuclei of female rats. J. Neurosci. 9 (1989) 3908-3914
108. Yu W.H., and Srinivasan R. Effect of testosterone and 5 alpha-dihydrotestosterone on regeneration of the hypoglossal nerve in rats. Exp. Neurol. 71 (1981) 431-435
109. Yue X., Lu M., Lancaster T., Cao P., Honda S., Staufenbiel M., Harada N., Zhong Z., Shen Y., and Li R. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19198-19203
110. Zhang Y., Champagne N., Beitel L.K., Goodyer C.G., Trifiro M., and LeBlanc A. Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70. J. Neurosci. 24 (2004) 5315-5321
111. Zheng H., Xu H., Uljon S.N., Gross R., Hardy K., Gaynor J., Lafrancois J., Simpkins J., Refolo L.M., Petanceska S., Wang R., and Duff K. Modulation of A(beta) peptides by estrogen in mouse models. J. Neurochem. 80 (2002) 191-196